Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.
1
Study Matches
A Phase 1a/b Trial of CG-806 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndromes
Study of safety and efficacy of CG-806 in patients with previously treated relapsed/refractory AML or Higher-Risk Myelodysplastic Syndromes
AML or high risk MDS whose disease has relapsed, is refractory or who are ineligible for or intolerant of intensive chemotherapy or transplantation Age ≥18 years. Life expectancy of at least 3 months.
Exclusion Criteria:
Acute promyelocytic leukemia Stem cell transplantation within 4 weeks prior to signing the informed consent form. Pregnant or lactating women.